Lumos Pharma Inc
NASDAQ:LUMO 3:41:58 PM EDT
| Market Cap (Intraday) | 22.54M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.71 |
| 50-Day MA | $2.84 |
| 200-Day MA | $3.11 |
Lumos Pharma Inc Stock, NASDAQ:LUMO
4200 Marathon Boulevard, Suite 200, Austin, Texas 78756
United States of America
Phone: +1.512.215.2630
Number of Employees: 33
Description
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.